Keyphrases
Phosphoinositide 3-kinase (PI3K)
100%
Apoptosis
100%
AKT Pathway
100%
Lymphoma Cells
100%
Nuclear factor-κB
100%
Primary Effusion Lymphoma
100%
Malignancy
22%
Multiple Myeloma
11%
Signaling Pathway
11%
Downstream Targets
11%
Pharmacological Inhibitors
11%
Therapeutic Potential
11%
Akt Phosphorylation
11%
Induced Apoptosis
11%
Constitutive Activation
11%
Small Interfering RNA (siRNA)
11%
Cell Viability
11%
Decreased Expression
11%
Gene Silencing
11%
Kinase Cascade
11%
B-cell Lymphoma
11%
Dose Effect
11%
Dephosphorylation
11%
Burkitt Lymphoma
11%
Apoptotic Effect
11%
Co-treatment
11%
LY294002
11%
AKT Inhibitor
11%
Apoptotic Response
11%
Nuclear Compartments
11%
Anti-apoptosis
11%
Suboptimal Dose
11%
Diffuse Large Cell
11%
Synergistic Targeting
11%
Medicine and Dentistry
Programmed Cell Death
100%
Phosphoinositide 3-Kinase
100%
Primary Effusion Lymphoma Cell Line
100%
Primary Effusion Lymphoma
100%
Lymphoma Cell
75%
3 (4 Tert Butylphenylsulfonyl) 2 Propenenitrile
50%
Cancer
25%
Gel Mobility Shift Assay
12%
LY294002
12%
Phosphotransferase
12%
Multiple Myeloma
12%
B-Cell Lymphoma
12%
Antiapoptotic
12%
Cell Viability
12%
Burkitt's Lymphoma
12%
Large Cell
12%
Gene Inactivation
12%
Signal Transduction
12%
Dephosphorylation
12%
RNAI
12%
Biochemistry, Genetics and Molecular Biology
Phosphoinositide 3-Kinase
100%
Signal Transduction
25%
Dephosphorylation
25%
Electrophoretic Mobility Shift Assay
25%
Cell Viability
25%
Gene Inactivation
25%
LY294002
25%
Kinase
25%
Phosphotransferase
25%
B Cell
25%
RNAI
25%
Pharmacology, Toxicology and Pharmaceutical Science
Primary Effusion Lymphoma
100%
Phosphatidylinositol 3 Kinase
100%
3 (4 Tert Butylphenylsulfonyl) 2 Propenenitrile
44%
Antiapoptotic
11%
Cell Viability
11%
Phosphotransferase
11%
B Cell Lymphoma
11%
2 Morpholino 8 Phenylchromone
11%
Electrophoretic Mobility Shift Assay
11%
Burkitt's Lymphoma
11%
Multiple Myeloma
11%